S. Nakata et al., Epidemiological study of the G serotype distribution of group a rotaviruses in Kenya from 1991 to 1994, J MED VIROL, 58(3), 1999, pp. 296-303
An epidemiological study on the G serotype distribution of group A rotaviru
ses (GARV) isolated in Kenya was carried out in one urban hospital in Nairo
bi and in two rural hospitals in Nanyuki and Kitui to clarify the prevalent
G serotypes before future introduction of the ready licensed rotavirus vac
cine in Kenya. A total of 1,431 stool specimens were collected from childre
n, who were mainly outpatients, aged from 0 to 6 yea rs old with acute gast
roenteritis from August 1991 to July 1994. Samples positive for GARV by con
ventional ELISA were then analyzed by subgrouping and serotyping ELISA and
by PAGE. To ascertain the G serotypes of viruses in samples that were unabl
e to be typed by serotyping ELISA, polymerase chain reaction was also attem
pted. The prevalence of GARV was 28.4% in the urban hospital, 22.5% in Nany
uki, and 13.7% in Kitui. Among rotavirus-positive samples, subgroup II rota
viruses were detected in 63.1%, and subgroup I rotaviruses were 25.9%. Sero
type G4 was most prevalent, accounting for 41.6% followed by 23.3% of serot
ype G1, 17.0% of serotype G2, and serotype G3 was rarely isolated. Seven st
rains of serotype G8/P1B rotavirus was detected for the first time in Kenya
by RT-PCR. Eleven specimens with an unusual composition of subgroup, serot
ype, and electropherotype were atypical GARV in which the P-serotype was P1
A, P1B, or P2. Although uncommon GARV serotype G8/P1B and atypical GARV wer
e detected, the four major GARV serotypes, G1 through G4, should be targete
d at this moment for vaccination to control this diarrheal disease in Kenya
, Continuous monitoring of the G- and P-serotype distribution of GARV shoul
d provide important information about the impact of rotavirus vaccination i
n Kenya. (C) 1999 Wiley-Liss, Inc.